NCT07090603

Brief Summary

The purpose of this study is to learn how aging affects muscle endurance during resistance exercise, and how oxygen delivery to the muscles plays a role in these changes. To answer this question, we are comparing how many repetitions of a leg exercise (knee extensions) younger and older adults can do at different exercise intensities. We will also look at how the muscles use oxygen during these exercises. Participants will take part in 12 different exercise sessions. In each session, they will perform as many knee extensions as possible using different amounts of weight-consisting of 20%, 30%, 40%, 50%, 60% and 70% of the maximum weight they can lift one time. Each weight will be tested both with and without a cuff on the leg that temporarily reduces blood flow to the muscle.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 21, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 29, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

July 29, 2025

Status Verified

July 1, 2025

Enrollment Period

7 months

First QC Date

July 21, 2025

Last Update Submit

July 21, 2025

Conditions

Keywords

muscle endurancemuscle contractioncritical occluding tensionmuscle oxygenationNIRSageingmuscle fatiguecontraction induced occlusion

Outcome Measures

Primary Outcomes (1)

  • Maximum repetitions performed during knee extension exercise

    The primary outcome of the study will be the maximum number of knee extension repetitions that participants are able to perform at varying resistive exercise loads.

    From enrollment to the end of the final study visit (~4 weeks)

Secondary Outcomes (1)

  • Local muscle tissue oxygenation during knee extension exercise

    From enrollment to the end of the final study visit (~ 4 weeks)

Study Arms (2)

Young cohort

EXPERIMENTAL

Young, healthy participants aged 19-35 will perform maximum repetitions of knee extension exercise at 20%, 30%, 40%, 50%, 60% and 70% of their one rep max with and without blood flow occlusion.

Other: Knee extension exercise

Older cohort

EXPERIMENTAL

Older, healthy participants aged 65 years and up will perform maximum repetitions of knee extension exercise at 20%, 30%, 40%, 50%, 60% and 70% of their one rep max with and without blood flow occlusion.

Other: Knee extension exercise

Interventions

Maximum repetitions of knee extension exercise at 20%, 30%, 40%, 50%, 60% and 70% of participants one rep max with and without blood flow occlusion

Older cohortYoung cohort

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to understand and communicate in English
  • years of age
  • years of age or older
  • All "No" answers on the CSEP Get Active questionnaire or doctors' approval to participate

You may not qualify if:

  • BMI lower than 18 or greater than 32
  • Current use of cigarettes or other nicotine devices
  • Any major uncontrolled cardiovascular, muscular, metabolic, and/or neurological disorders
  • Any medical condition impacting the ability to participate in maximal exercise
  • Type one or type two diabetes
  • Diagnosis of cancer or undergoing cancer treatment in the past 12 months
  • Taking blood-thinning medication or the presence of a bleeding disorder
  • Drug therapy with any drugs that alter skeletal muscle metabolism (i.e., Metformin, Benzodiazepines)
  • Lowest calculated exercise testing load is less than the lightest weight able to be provided by the lab gymnasium equipment
  • In the past six months, completing more than 300 minutes of moderate physical activity or 150 minutes of vigorous physical activity per week
  • In the past six months, completing less than 150 minutes of moderate physical activity or 75 minutes of vigorous physical activity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chan Gunn Pavilion

Vancouver, British Columbia, V6T 1Z3, Canada

Location

Study Officials

  • Cameron J Mitchell, PhD (Kinesiology)

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abaigeal L Kelso

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 21, 2025

First Posted

July 29, 2025

Study Start

September 1, 2025

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

July 29, 2025

Record last verified: 2025-07

Locations